RAPT Therapeutics, Inc.

RAPT Therapeutics is a clinical-stage immunology-based biopharmaceutical company that discovers, develops, and commercializes novel oral small molecule therapies. The company focuses on addressing significant unmet needs in inflammatory and immunologic diseases, including oncology. They utilize a proprietary drug discovery and development engine to create highly selective small molecules designed to modulate critical immune responses.